In order to address the specific details and regulatory requirements present in a retrospective medical chart review, the UB IRB recently created a new Protocol template: the HRP-503R.
The new institute will streamline efforts to turn groundbreaking drug research into viable treatments and medicines, bringing new companies and new jobs.
